References
Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotorexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.Blood. 2000;96:2062–2068.
Deeg HJ, Loughran TP Jr, Storb R, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.Transplantation. 1985; 40:162–166.
Basara N, Kiehl MG, Blau W, et al. Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.Transplant Proc. 2001; 33:2121–2123.
Racadot E, Milpied N, Bordigoni P, et al. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.Bone Marrow Transplant. 1995;15:669–677.
Dugan MJ, DeFor TE, Steinbuch M, et al. ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival.Ann Hematol. 1997;75:41–46.
McCaul KG, Nevill TJ, Barnett MJ, et al. Treatment of steroid- resistant acute graft-versus-host disease with rabbit antithymocyte globulin.J Hematother Stem Cell Res. 2000;9:367–374.
Khoury H, Kashyap A, Adkins DR, et al. Treatment of steroid- resistant acute graft-versus-host disease with anti-thymocyte globulin.Bone Marrow Transplant. 2001;27:1059–1064.
Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.Br J Haematol. 1997;97:855–864.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ohashi, K., Tanaka, Y., Mori, Si. et al. Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease. Int J Hematol 77, 99–102 (2003). https://doi.org/10.1007/BF02982612
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982612